World

Johnson & Johnson (NYSE: JNJ), (BNTX) – Johnson & Johnson says that late-stage coronavirus vaccine trials were advanced to September

Johnson and Johnson (NYSE: JNJ) said Thursday it would begin late-stage human trials for its COVID-19 vaccine earlier than scheduled in September, and that phase one trials involving 1,000 people will begin next week. What happened New Jersey-based company Chief Scientific Officer Paul Stoffels revealed in a profit call that …

Read More »